The global biosimilar monoclonal antibody market revenue was around US$ 10.6 billion in 2023 and is estimated to reach US$ 64.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 22.2 ...
A new report from JLL projects data center inventory will reach 200 gigawatts by the end of the decade as tech giants pour ...
Adding some high-octane dividend growth stocks could give your portfolio a boost in 2026. Brookfield Asset Management ( BAM ...
Waste Management (NYSE:WM) -0.7% in Tuesday's trading after setting growth targets through 2027, including 9.4% compound annual growth rate for revenues to $28.88B in 2027, above analyst consensus of ...
CoStar Group (CSGP) sees FY26 revenue between $3.78 billion to $3.82 billion, ~+18% Y/Y over the midpoint of our previously ...
Turning a $10,000 investment in stock into $1 million in a decade is a very ambitious target. To achieve this exceptional goal of 100x returns, a stock has to grow at a minimal compound annual growth ...
AppLovin (APP) delivered a 3,980% return over three years and surpassed Nvidia and Palantir combined. AppLovin’s software platform revenue grew at a 94% compound annual growth rate over five years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback